Active Substance & Generic Molecule Directory
Resveratrol in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Resveratrol registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:10 Supplements (MAL-N)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL20172820NC | E-Resveratrol 150mg CAPSULE | 150.00mg 300.00mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL20026101NC | MB RESVERATROL Q10 CAPSULE | 100 mg 500 mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL21026125NC | MITO-RESQ CAPSULE | 150 mg 510 mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL19076114N | NUTRILIVING RESVERATROL 150MG CAPSULE | 150.012mg 270mg | Health Supplement (MAL-N) | Sky Nutraceuticals Sdn. Bhd. | Compare → |
| MAL26026103N | REANEU ACNCLR TABLET | 50 mg 824 mg | Health Supplement (MAL-N) | Sky Nutraceuticals Sdn. Bhd. | Compare → |
| MAL26046098N | REANEU WINKSMT TABLET | 50 mg 599.46 mg | Health Supplement (MAL-N) | Sky Nutraceuticals Sdn. Bhd. | Compare → |
| MAL23016066N | REOXlife iMgard Capsule | 25 mg 350 mg | Health Supplement (MAL-N) | BRAND8 NUTRACEUTICAL SDN. BHD. | Compare → |
| MAL23016089N | REOXlife iMgard Powder | 25 mg 2 gm | Health Supplement (MAL-N) | BRAND8 NUTRACEUTICAL SDN. BHD. | Compare → |
| MAL18086060NC | RESVERAXIN CAPSULE | 150 mg 330 mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL18016153NC | VERISTROL CAPSULE | 250 mg 370 mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.